Lord, Abbett & Co. LLC Orchard Therapeutics PLC Transaction History

Lord, Abbett & Co. LLC

  • $30.7 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 09, 2021
SELL
$2.24 - $4.29 $3.64 Million - $6.98 Million
-1,626,603 Closed
0 $0
Q2 2021

Aug 11, 2021
SELL
$4.39 - $7.23 $626,426 - $1.03 Million
-142,694 Reduced 8.07%
1,626,603 $7.14 Million
Q1 2021

May 11, 2021
BUY
$4.39 - $9.08 $7.77 Million - $16.1 Million
1,769,297 New
1,769,297 $12.8 Million

Others Institutions Holding ORTX

# of Institutions
4
Shares Held
545K
Call Options Held
0
Put Options Held
0
View Full List

About Orchard Therapeutics plc

ORTX Quotes by TradingView
  • Ticker ORTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,458,000
  • Description
  • Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...
More about ORTX
Track This Portfolio

Track Lord, Abbett & Co. LLC Portfolio

Follow Lord, Abbett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email